Indian Generic Pharma Brands Booming – Avendus Capital Reports

The investment banking firm found X18 growth of generic brands from just 21 in FY 2009 to an impressive 388 in FY 2024, each earning over $14mn annually.

 

These brands, which make up 44% of the domestic $26.67bn market, have attracted $14bn+ of investment since 2018 and should expect a further 30% growth in revenue, according to Avendus’ MD.

28 Mar
76°F
29 Mar
75°F
30 Mar
79°F
31 Mar
75°F
1 Apr
69°F
2 Apr
75°F
3 Apr
81°F
28 Mar
76°F
29 Mar
75°F
30 Mar
79°F
31 Mar
75°F
1 Apr
69°F
2 Apr
75°F
3 Apr
81°F
Light
Dark